NCT00682032

The Effect of Beta-glucan in Non-Small Cell Lung Cancer

Beta-glucan's Immuno-modulatory Effect on Non-Small Cell Lung Cancer

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 300 (estimated)
• Sponsor: University of Louisville · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine how beta-glucan affects the immune system in subjects with non-small cell lung cancer.

Detailed description

Beta-glucan (Imucell WGP) is an over-the-counter dietary supplement that enhances the body's immune system. Imucell WGP is extracted from food-grade baker's yeast, which is permitted for use in food by the U.S. Food and Drug Administration (FDA). Studies in animals have shown that Imucell WGP helps trigger white blood cells to destroy cancer cells. Other animal studies combining Imucell WGP with anti-cancer medications have shown greater tumor regression and tumor-free survival.

Conditions

• Non Small Cell Lung Cancer

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	beta-glucan	AIM 2: regimen to begin after baseline blood draw; AIM 3: regimen to begin after baseline blood draw and to be completed prior to surgery

Timeline

• Start date: 2008-10-01
• Primary completion: 2025-04-01
• Completion: 2029-03-01
• First posted: 2008-05-21
• Last updated: 2025-01-10

Locations

1 site across 1 country: United States